New cancer research building: Boosting innovation in oncology
With our new cancer research building in Vienna, we’ll advance our oncology pipeline and strengthen our commitment to innovation and collaboration.
Search
Our innovation strategy
Our Innovation Strategy at Boehringer Ingelheim in Research and Development
Partnering
We are convinced that diversity and exchange in science give birth to innovations. For this reason, partnerships are an important component of our innovation strategy.
Dog parasites: What you should know
Dog parasites: What you should know
Research Beyond Borders
Learn more about how our Research Beyond Borders team is uncovering new ideas and new science.
COPD
COPD
Improving the current state of schizophrenia care
A closer look at the status of the schizophrenia care landscape, an often misunderstood mental health condition
About Us
About Us
Ruminants
Ruminants
Regional Center Vienna
RCV is the regional affiliate of Boehringer Ingelheim and responsible for over 30 countries in Central and Eastern Europe and Central Asia.
Science Stories
Science Stories
Chronic Kidney Disease
Chronic Kidney Disease, or CKD, is caused by progressive damage to the kidneys, affecting 10% of the population.
Data Science: Revolutionizing research and development with data driven insights
Using data in pharmaceutical research to better address patient needs
Lung Diseases
Lung Diseases
Corporate Profile
Corporate Profile
Hypertension
Hypertension
Mental Health
Boehringer Ingelheim has a range of different compounds in development for Central Nervous System (CNS) diseases, some in advanced clinical phases.
NASH
NASH
Rabies? Not in Mexico!
Mexico has been a rabies-free country for the last five years. How does Mexico achieve this? Learn how we're collaborating in this fight against rabies.
Patient Safety & Pharmacovigilance at Boehringer Ingelheim
Patients inspire us in our mission to lead the science that creates breakthrough therapies, so that our medicines transform patients’ lives.
Reimagining digital healthcare worldwide
How does our digital lab BI X innovate in Ingelheim and Shanghai? Read about success stories based on different ideation processes
Biotherapeutics Discovery
Our committed team of scientists are using all their experience and knowledge to forge new research paths, engineer new molecules and do whatever it takes to make sure that no patient is left behind in our search for the next breakthrough.
About Our Innovation Prize
Celebrating Our Innovation Prize Winners
Digital innovation: „We change the way labs work“
QUDA – an in-house software – changes the way labs work. It increases our quality assurance and our drug saftey.
75 Years Boehringer Ingelheim in Austria
75 Years Boehringer Ingelheim in Austria